Systems-ADME/Tox: Resources and network approaches

Journal of Pharmacological and Toxicological Methods

Volumn 53, Issue 1, 2006, Pages 38-66

  Ekins, Sean ^a,b  

^a GeneGo bioinformatics software Inc   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Algorithms; Human; Microarray; Mouse; Networks; Rat; Software; Toxicogenomics; Toxicoproteomics

Indexed keywords

2 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 4 (3 OXO 1,2,4 TRIAZOL 5 YLMETHYL) 3 PHENYLMORPHOLINE; ABC TRANSPORTER A1; AMPHOTERICIN B; BEMITRADINE; BEZAFIBRATE; BUPIVACAINE; CALCITRIOL; CIPROFIBRATE; CISPLATIN; CLOFIBRATE; CLOTRIMAZOLE; DEXAMETHASONE; ETHINYLESTRADIOL; ETOFIBRATE; FENOFIBRATE; GEMFIBROZIL; GENISTEIN; ISONIAZID; METHAPYRILENE; METHOTREXATE; MICONAZOLE; MITOMYCIN C; OUABAIN; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; SULINDAC SULFIDE; TROLEANDOMYCIN; UNINDEXED DRUG; VALPROIC ACID;

ALGORITHM; DATA ANALYSIS SOFTWARE; DNA MICROARRAY; DNA POLYMORPHISM; DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; DRUG TRANSPORT; GENE EXPRESSION; GENE INTERACTION; HIGH THROUGHPUT SCREENING; HUMAN; LIVER TOXICITY; MATHEMATICAL MODEL; NEPHROTOXICITY; NONHUMAN; PROTEIN INTERACTION; PROTEOMICS; REVIEW; SYSTEMS BIOLOGY; TOXICOGENETICS;

STROPHANTHUS GRATUS;

EID: 30144443169     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2005.05.005     Document Type: Article

References (210)

1. M. Abe, S. Yamashita, T. Kuramoto, Y. Hirayama, T. Tsukamoto, and T. Ohta Global expression analysis of N-methyl-N′-nitro-N-nitrosoguanidine- induced rat stomach carcinomas using oligonucleotide microarrays Carcinogenesis 24 2003 861 867
2. T. Adachi, Y. Ono, K.B. Koh, K. Takashima, H. Tainaka, and Y. Matsuno Long-term alteration of gene expression without morphological change in testis after neonatal exposure to genistein in mice: Toxicogenomic analysis using cDNA microarray Food and Chemical Toxicology 42 2004 445 452
3. G.S. Akerman, B.A. Rosenzweig, O.E. Domon, L.J. McGarrity, L.R. Blankenship, and C.A. Tsai Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells Mutation Research 549 2004 43 64
4. S.V. Aksenov, B. Church, A. Dhiman, A. Georgieva, R. Sarangapani, and G. Helmlinger An integrated approach for inference and mechanistic modeling for advancing drug development FEBS Letters 579 2005 1878 1883
5. P. Anderle, Y. Huang, and W. Sadee Intestinal membrane transport of drugs and nutrients: Genomics of membrane transporters using expression microarrays European Journal of Pharmaceutical Sciences 21 2004 17 24
6. J.P. Annereau, G. Szakacs, C.J. Tucker, A. Arciello, C. Cardarelli, and J. Collins Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance Molecular Pharmacology 66 2004 1397 1405
7. G. Apic, T. Ignjatovic, S. Boyer, and R.B. Russell Illuminating drug discovery with biological pathways FEBS Letters 579 2005 1872 1877
8. V.A. Baker, H.M. Harries, J.F. Waring, C.M. Duggan, H.A. Ni, and R.A. Jolly Clofibrate-induced gene expression changes in rat liver: A cross-laboratory analysis using membrane cDNA arrays Environmental Health Perspectives 112 2004 428 438
9. K.V. Balakin, S. Ekins, A. Bugrim, Y.A. Ivanenkov, D. Korolev, and Y. Nikolsky Quantitative structure-metabolism relationship modeling of the metabolic N-dealkylation rates Drug Metabolism and Disposition 32 2004 1111 1120
10. K.V. Balakin, S. Ekins, A. Bugrim, Y.A. Ivanenkov, D. Korolev, and Y. Nikolsky Kohonen maps for prediction of binding to human cytochrome P450 3A4 Drug Metabolism and Disposition 32 2004 1183 1189
11. A.-L. Barabasi, and Z.N. Oltvai Network biology: Understanding the cell's functional organization Nature Reviews Genetics 5 2004 101 113
12. M. Bartosiewicz, S.G. Penn, and A. Buckpitt Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene Environmental Health Perspectives 109 2001 71 74
13. G. Bertilsson, J. Heidrich, K. Svensson, M. Asman, L. Jendeberg, and M. Sydow-Backman Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction Proceedings of the National Academy of Sciences of the United States of America 95 1998 12208 12213
14. B. Blumberg, W. Sabbagh Jr., H. Juguilon, J. Bolado Jr., C.M. van Meter, and E.S. Ong SXR, a novel steroid and xenobiotic-sensing nuclear receptor Genes and Development 12 1998 3195 3205
15. Y. Borodina, A. Rudik, D. Filimonov, N. Kharchevnikova, A. Dmitriev, and V. Blinova A new statistical approach to predicting aromatic hydroxylation sites. Comparison with model-based approaches Journal of Chemical Information and Computer Sciences 44 2004 1998 2009
16. Y. Borodina, A. Sadym, D. Filimonov, V. Blinova, A. Dmitriev, and V. Poroikov Predicting biotransformation potential from molecular structure Journal of Chemical Information and Computer Sciences 43 2003 1636 1646
17. F.G. Bottone Jr., J.M. Martinez, J.B. Collins, C.A. Afshari, and T.E. Eling Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: Possible link to apoptosis Journal of Biological Chemistry 278 2003 25790 25801
18. S. Boyer, and I. Zamora New methods in predictive metabolism Journal of Computer-Aided Molecular Design 16 2002 403 413
19. M. Bredel, and E. Jacoby Chemogenomics: An emerging strategy for rapid target and drug discovery Nature Reviews. Genetics 5 2004 262 275
20. A. Bugrim, T. Nikolskaya, and Y. Nikolsky Early prediction of drug metabolism and toxicity: Systems biology approach and modeling Drug Discovery Today 9 2004 127 135
21. S.J. Bulera, S.M. Eddy, E. Ferguson, T.A. Jatkoe, J.F. Reindel, and M.R. Bleavins RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays Hepatology 33 2001 1239 1258
22. E.C. Butcher, E.L. Berg, and E.J. Kunkel Systems biology in drug discovery Nature Biotechnology 22 2004 1253 1259
23. A. Butte The use and analysis of microarray data Naturalist Review of Drug Discovery 1 2002 951 960
24. M.P. Cary, G.D. Bader, and C. Sander Pathway information for systems biology FEBS Letters 579 2005 1815 1820
25. M.H. Cheok, W. Yang, C.H. Pui, J.R. Downing, C. Cheng, and C.W. Naeve Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells Nature Genetics 34 2003 85 90
26. J.D. Cleary, P.D. Rogers, and S.W. Chapman Differential transcription factor expression in human mononuclear cells in response to amphotericin B: Identification with complementary DNA microarray technology Pharmacotherapy 21 2001 1046 1054
27. M. Coen, S.U. Ruepp, J.C. Lindon, J.K. Nicholson, F. Pognan, and E.M. Lenz Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse Journal of Pharmaceutical and Biomedical Analysis 35 2004 93 105
28. P.D. Cornwell, A.T. De Souza, and R.G. Ulrich Profiling of hepatic gene expression in rats treated with fibric acid analogs Mutation Research 549 2004 131 145
29. P. Csermely, V. Agoston, and S. Pongor The efficiency of multi-target drugs: The network approach might help drug design Trends in Pharmacological Sciences 26 2005 178 182
30. M.J. Cunningham, S. Liang, S. Fuhrman, J.J. Seilhamer, and R. Somogyi Gene expression microarray data analysis for toxicology profiling Annals of the New York Academy of Sciences 919 2000 52 67
31. F. de Longueville, F.A. Atienzar, L. Marcq, S. Dufrane, S. Evrard, and L. Wouters Use of a low density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes Toxicological Sciences 75 2003 378 392
32. R. Dobrin, Q.K. Beg, A.L. Barabasi, and Z.N. Oltvai Aggregation of topological motifs in the Escherichia coli transcriptional regulatory network BMC Bioinformatics 5 2004 10
33. S. Donald, R.D. Verschoyle, R. Edwards, D.J. Judah, R. Davies, and J. Riley Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat Cancer Research 62 2002 4256 4262
34. M. Dumont, E. Jacquemin, C. D'Hont, C. Descout, D. Cresteil, and D. Haouzi Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation Journal of Hepatology 27 1997 1051 1056
35. C. Durnas, C.M. Loi, and B.J. Cusack Hepatic drug metabolism and aging Clinical Pharmacokinetics 19 1990 359 389
36. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proceedings of the National Academy of Sciences of the United States of America 95 1998 14863 14868
37. Ekins, S., Andreyev, S., Ryabov, A., Kirilov, E., Rakhmatulin, E. A., Bugrim, A., et al. (in press). Computational Prediction of Human Drug Metabolism. Exp Opin Drug Metab Toxicol.
38. S. Ekins, B. Boulanger, P.W. Swaan, and M.A.Z. Hupcey Towards a new age of virtual ADME/TOX and multidimensional drug discovery Journal of Computer-Aided Molecular Design 16 2002 381 401
39. S. Ekins, A. Bugrim, Y. Nikolsky, and T. Nikolskaya Systems biology: Applications in drug discovery S. Gad Drug Discovery Handbook 2005 Wiley and Sons Hoboken, NJ 123 183
40. S. Ekins, C.N. Giroux, Y. Nikolsky, A. Bugrim, and T. Nikolskaya A signature gene network approach to toxicity The Toxocologists 84 2005
41. S. Ekins, E. Kirillov, E. Rakhmatulin, and T. Nikolskaya A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism Drug Metabolism and Disposition 33 2005 474 481
42. S. Ekins, and R.J. McGowan The limits of reductionism: The shifting genomic paradigm's impact on industry and academia Philsophy in Science 9 2001 1 23
43. S. Ekins, L. Mirny, and E.G. Schuetz A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRa and LXRb Pharmaceutical Research 19 2002 1788 1800
44. S. Ekins, Y. Nikolsky, and T. Nikolskaya Techniques: Application of systems biology to absorption, distribution, metabolism, excretion, and toxicity Trends in Pharmacological Sciences 26 2005 202 209
45. S. Ekins, B.J. Ring, J. Grace, D.J. McRobie-Belle, and S.A. Wrighton Present and future in vitro approaches for drug metabolism Journal of Pharmacological and Toxicological Methods 44 2000 313 324
46. S. Ekins, C.L. Waller, P.W. Swaan, G. Cruciani, S.A. Wrighton, and J.H. Wikel Progress in predicting human ADME parameters in silico Journal of Pharmacological and Toxicological Methods 44 2000 251 272
47. P.W. Erhardt A human drug metabolism database: Potential roles in the quantitative predictions of drug metabolism and metabolism-related drug-drug interactions Current Drug Metabolism 4 2003 411 422
48. W.E. Evans, and H.L. McLeod Pharmacogenomics-drug disposition, drug targets, and side effects New England Journal of Medicine 348 2003 538 549
49. J. Ezendam, F. Staedtler, J. Pennings, R.J. Vandebriel, R. Pieters, and P. Boffetta Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats Environmental Health Perspectives 112 2004 782 791
50. B. Faiola, E.S. Fuller, V.A. Wong, and L. Recio Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene Mutation Research 549 2004 195 212
51. FDA Innovation stagnation: Challenge and opportunity on the critical path to new medicinal products 2004
52. O. Fiehn Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks Comparative Functional Genomics 2 2001 155 168
53. F.J. Field, E. Born, and S.N. Mathur LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells Journal of Lipid Research 45 2004 905 913
54. C. Fleck, L. Sutter, D. Appenroth, B. Koch, T. Meinhold, and M. Pitack Use of gene chip technology for the characterisation of the regulation of renal transport processes and of nephrotoxicity in rats Experimental and Toxicologic Pathology 54 2003 401 410
55. A.F. Fliri, W.T. Loging, P.F. Thadeio, and R.A. Volkmann Biological spectra analysis: Linking biological activity profiles to molecular structure Proceedings of the National Academy of Sciences of the United States of America 102 2005 261 266
56. M. Fountoulakis Application of proteomics technologies in the investigation of the brain Mass Spectrometry Reviews 23 2004 231 258
57. S.P. Gaucher, S.W. Taylor, E. Fahy, B. Zhang, D.E. Warnock, and S.S. Ghosh Expanded coverage of the human heart mitochondrial proteome using multidimensional liquid chromatography coupled with tandem mass spectrometry Journal of Proteome Research 3 2004 495 505
58. D. Gerhold, M. Lu, J. Xu, C. Austin, C.T. Caskey, and T. Rushmore Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays Physiological Genomics 5 2001 161 170
59. G.L. Guo, S. Choudhuri, and C.D. Klaassen Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways Journal of Pharmacology and Experimental Therapeutics 300 2002 206 212
60. B. Hagenbuch, and P.J. Meier Organic anion transporting polypeptides of the OATP/ SLC21 family: Phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Archiv 447 2004 653 665
61. H.K. Hamadeh, and C.A. Afshari Toxicogenomics principles and applications 2004 John Wiley and Sons Hoboken
62. H.K. Hamadeh, P.R. Bushel, S. Jayadev, K. Martin, O. DiSorbo, and S. Sieber Gene expression analysis reveals chemical-specific profiles Toxicological Sciences 67 2002 219 231
63. H.K. Hamadeh, S. Jayadev, E.T. Gaillard, Q. Huang, R. Stoll, and K. Blanchard Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity Mutation Research 549 2004 169 183
64. H.K. Hamadeh, B.L. Knight, A.C. Haugen, S. Sieber, R.P. Amin, and P.R. Bushel Methapyrilene toxicity: Anchorage of pathologic observations to gene expression alterations Toxicologic Pathology 30 2002 470 482
65. J.D. Han, N. Bertin, T. Hao, D.S. Goldberg, G.F. Berriz, and L.V. Zhang Evidence for dynamically organized modularity in the yeast protein-protein interaction network Nature 430 2004 88 93
66. D. Hanisch, A. Zien, R. Zimmer, and T. Lengauer Co-clustering of biological networks and gene expression data Bioinformatics 18 2002 S145 S154
67. A.J. Harris, S.L. Dial, and D.A. Casciano Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells Mutation Research 549 2004 79 99
68. S.C. Harrison Whither structural biology Nature Structural Molecular Biology 11 2004 12 15
69. D.P. Hartley, X. Dai, Y.D. He, E.J. Carlini, B. Wang, and S.E. Huskey Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression Molecular Pharmacology 65 2004 1159 1171
70. L.H. Hartwell, J.J. Hopfield, S. Leibler, and A.W. Murray From molecular to modular cell biology Nature 402 1999 C47 C52
71. S. Hasmall, G. Orphanides, N. James, W. Pennie, K. Hedley, and A. Soames Downregulation of lactoferrin by PPARalpha ligands: Role in perturbation of hepatocyte proliferation and apoptosis Toxicology Sciences 68 2002 304 313
72. T. Hayase, Y. Yamamoto, K. Yamamoto, E. Muso, and K. Shiota Microarray profile analysis of toxic cocaine-induced alterations in the expression of mouse brain gene sequences: A possible 'protective' effect of buprenorphine Journal of Applied Toxicology 24 2004 15 20
73. K.R. Hayes, A.L. Vollrath, G.M. Zastrow, B.J. McMillan, M. Craven, and S. Jovanovich EDGE: A centralized resource for the comparison, analysis, and distribution of toxicogenomic information Molecular Pharmacology 67 2005 1360 1368
74. W.H. Heijne, A.L. Slitt, P.J. van Bladeren, J.P. Groten, C.D. Klaassen, and R.H. Stierum Bromobenzene-induced hepatotoxicity at the transcriptome level Toxicology Sciences 79 2004 411 422
75. W.H. Heijne, R.H. Stierum, M. Slijper, P.J. van Bladeren, and B. van Ommen Toxicogenomics of bromobenzene hepatotoxicity: A combined transcriptomics and proteomics approach Biochemical Pharmacology 65 2003 857 875
76. A.N. Heinloth, R.D. Irwin, G.A. Boorman, P. Nettesheim, R.D. Fannin, and S.O. Sieber Gene expression profiling of rat livers reveals indicators of potential adverse effects Toxicology Sciences 80 2004 193 202
77. L.C. Hodges, J.D. Cook, E.K. Lobenhofer, L. Li, L. Bennett, and P.R. Bushel Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells Molecular Cancer Research 1 2003 300 311
78. A. Holleman, M.H. Cheok, M.L. den Boer, W. Yang, A.J. Veerman, and K.M. Kazemier Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment New England Journal of Medicine 351 2004 533 542
79. Y. Hong, U.R. Muller, and F. Lai Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays Toxicology in Vitro 17 2003 85 92
80. E. Hood Proteomics: Characterizing the cogs in the machinery of life Environmental Health Perspectives 111 2003 A816 A825
81. L. Hood Systems biology: Integrating technology, biology, and computation Mechanism of Ageing and Development 124 2003 9 16
82. L. Hood, and D. Galas The digital code of DNA Nature 421 2003 444 448
83. L. Hood, and R.M. Perlmutter The impact of systems approaches on biological problems in drug discovery Nature Biotechnology 22 2004 1215 1217
84. T. Hu, D.P. Gibson, G.J. Carr, S.M. Torontali, J.P. Tiesman, and J.G. Chaney Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins Mutation Research 549 2004 5 27
85. Q. Huang, R.T. Dunn II, S. Jayadev, O. DiSorbo, F.D. Pack, and S.B. Farr Assessment of cisplatin-induced nephrotoxicity by microarray technology Toxicology Sciences 63 2001 196 207
86. Q. Huang, X. Jin, E.T. Gaillard, B.L. Knight, F.D. Pack, and J.H. Stoltz Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants Mutation Research 549 2004 147 167
87. M.T. Huisman, J.W. Smit, K.M. Crommentuyn, N. Zelcer, H.R. Wiltshire, and J.H. Beijnen Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs Aids 16 2002 2295 2301
88. C.M. Hunt, W.R. Westerkam, and G.M. Stave Effect of age and gender on the activity of human hepatic CYP3A Biochemical Pharmacology 44 1992 275 283
89. T. Ideker, O. Ozier, B. Schwikowski, and A.F. Siegal Discovering regulatory and signalling circuits in molecular interaction networks Bioinformatics 18 2002 S233 S240
90. T. Ideker, V. Thorsson, J.A. Ranish, R. Christmas, J. Buhler, and J.K. Eng Integrated genomic and proteomic analyses of a systematically perturbed network Science 292 2001 929 934
91. M. Iida, C.H. Anna, J. Hartis, M. Bruno, B. Wetmore, and J.R. Dubin Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis 24 2003 757 770
92. M. Ingelman-Sundberg Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future Trends in Pharmacological Sciences 25 2004 193 200
93. H. Jeong, S.P. Mason, A.L. Barabasi, and Z.N. Oltvai Lethality and centrality in protein networks Nature 411 2001 41 42
94. H. Jeong, B. Tombor, R. Albert, Z.N. Oltvai, and A.L. Barabasi The large-scale organization of metabolic networks Nature 407 2000 651 654
95. D. Jung, B. Hagenbuch, L. Gresh, M. Pontoglio, P.J. Meier, and G.A. Kullak-Ublick Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha Journal of Biological Chemistry 276 2001 37206 37214
96. D. Jung, and G.A. Kullak-Ublick Hepatocyte nuclear factor 1 alpha: A key mediator of the effect of bile acids on gene expression Hepatology 37 2003 622 631
97. J.-W. Jung, J.-S. Park, J.-W. Hwang, K.-S. Kang, L. Y.S., and B.-S. Song Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarray Journal of Veterinary Medical Science 66 2004 1329 1333
98. N. Kato, M. Shibutani, H. Takagi, C. Uneyama, K.-Y. Lee, and S. Takiami Gene expression profile in the livers of rats orally administered ethinylestradiol for 28 days using a microarray technique Toxicology 200 2004 179 192
99. L.D. Kier, R. Neft, L. Tang, R. Suizu, T. Cook, and K. Onsurez Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro Mutation Research 549 2004 101 113
100. K. Kijima, K. Toyosawa, M. Yasuba, N. Matsuoka, T. Adachi, and M. Komiyama Gene expression analysis of the rat testis after treatment with di(2-ethylhexyl) phthalate using cDNA microarray and real-time RT-PCR Toxicology and Applied Pharmacology 200 2004 103 110
101. R.B. Kim Organic anion-transporting polypeptide (OATP) transporter family and drug disposition European Journal of Clinical Investigation 33 2003 1 5
102. M.T. Kinirons, and M.S. O'Mahony Drug metabolism and ageing British Journal of Clinical Pharmacology 57 2004 540 544
103. H. Kitano Computational systems biology Nature 420 2002 206 210
104. H. Kitano Systems biology: A brief overview Science 295 2002 1662 1664
105. S.A. Kliewer, J.T. Moore, L. Wade, J.L. Staudinger, M.A. Watson, and S.A. Jones An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway Cell 92 1998 73 82
106. D. Korolev, K.V. Balakin, Y. Nikolsky, E. Kirillov, Y.A. Ivanenkov, and N.P. Savchuk Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach Journal of Medicinal Chemistry 46 2003 3631 3643
107. J.A. Kramer, S.D. Pettit, R.P. Amin, T.A. Bertram, B. Car, and M. Cunningham Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment Environmental Health Perspectives 112 2004 460 464
108. K. Kultima, A.-M. Nystrom, B. Scholz, A.-L. Gustafson, L. Dencker, and M. Stigson Valproic acid teratogenicity: A toxicogenomics approach Environmental Health Perspectives 112 2004 1225 1235
109. G.D. Kutuzova, and H.F. Deluca Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties Archives of Biochemistry and Biophysics 432 2004 152 166
110. M.K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T.W. Kensler Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival Journal of Biological Chemistry 278 2003 8135 8145
111. K. Lahjouji, G.A. Mitchell, and I.A. Qureshi Carnitine transport by organic cation transporters and systemic carnitine deficiency Molecular Genetics and Metabolism 73 2001 287 297
112. C.P. Landowski, D. Sun, D.R. Foster, S.S. Menon, J.L. Barnett, and L.S. Welage Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters Journal of Pharmacology and Experimental Therapeutics 306 2003 778 786
113. G.-J. Lee, W.-S. Lee, K.-S. Jeon, C.-H. Um, S.-J. Kim, and C.-H. Lee cDNA microarray gene expression analysis and toxicological phenotype for anticancer drug Journal of Veterinary Medical Science 66 2004 1339 1345
114. M. Lee, J. Kwon, S.N. Kim, J.E. Kim, W.S. Koh, and E.J. Kim cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p-anisidine, genotoxic compounds with differing tumorigenicity results Environmental and Molecular Mutagenesis 42 2003 91 97
115. S. Li, C.M. Armstrong, N. Bertin, H. Ge, S. Milstein, and M. Boxem A map of the interactome network of the metazoan C. elegans Science 303 2004 540 543
116. M.J. Liguori, L.M. Anderson, S. Bukofzer, J. McKim, J.F. Pregenzer, and J. Retief Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin Hepatology 41 2005 177 186
117. E.K. Lobenhofer, L. Bennett, P.L. Cable, L. Li, P.R. Bushel, and C.A. Afshari Regulation of DNA replication fork genes by 17beta-estradiol Molecular Endocrinology 16 2002 1215 1229
118. J. Locker, J. Tian, R. Carver, D. Concas, C. Cossu, and G.M. Ledda-Columbano A common set of immediate-early response genes in liver regeneration and hyperplasia Hepatology 38 2003 314 325
119. W.B. Mattes, S.D. Pettit, S.A. Sansone, P.R. Bushel, and M.D. Waters Database development in toxicogenomics: Issues and efforts Environmental Health Perspectives 112 2004 495 505
120. M. McMillian, A.Y. Nie, J.B. Parker, A. Leone, S. Bryant, and M. Kemmerer A gene expression signature for oxidant stress/reactive metabolites in rat liver Biochemical Pharmacology 68 2004 2249 2261
121. P.J. Meier, and B. Stieger Molecular mechanisms in bile formation News in Physiological Sciences 15 2000 89 93
122. G. Meneses-Lorente, F. de Longueville, S. Dos Santos-Mendes, T.P. Bonnert, A. Jack, and S. Evrard An evaluation of a low-density DNA microarray using cytochrome P450 inducers Chemical Research in Toxicology 16 2003 1070 1077
123. G. Meneses-Lorente, P.C. Guest, J. Lawrence, N. Muniappa, M.R. Knowles, and H.A. Skynner A proteomic investigation of drug-induced steatosis in rat liver Chemical Research in Toxicology 17 2004 605 612
124. C.L. Merrill, H. Ni, L.W. Yoon, M.A. Tirmenstein, P. Narayanan, and G.R. Benavides Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically Toxicology Sciences 68 2002 93 101
125. R. Milo, S. Shen-Orr, S. Itzkovitz, N. Kashtan, D. Chklovskii, and U. Alon Network motifs: Simple building blocks of complex networks Science 298 2002 824 827
126. K.T. Morgan, H. Ni, H.R. Brown, L. Yoon, C.W. Qualls, and L.M. Crosby Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cells Toxicologic Pathology 30 2002 435 451
127. J. Mwinyi, A. Johne, S. Bauer, I. Roots, and T. Gerloff Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics Clinical Pharmacology and Therapeutics 75 2004 415 421
128. K. Nakata, M. Yukawa, N. Komiyama, T. Nakano, and T. Kaminuma A nuclear receptor database that maps pathways to diseases Genome Infomatics 13 2002 515 516
129. J.K. Nicholson, E. Holmes, J.C. Lindon, and I.D. Wilson The challenges of modeling mammalian biocomplexity Nature Biotechnology 22 2004 1268 1274
130. J.K. Nicholson, and I.D. Wilson Understanding 'global, systems biology: Metabonomics and the continuum of metabolism Nature Reviews on Drug Discovery 2 2003 668 676
131. A. Nikitin, S. Egorov, N. Daraselia, and I. Mazo Pathway studio-the analysis and navigation of molecular networks Bioinformatics 19 2003 2155 2157
132. Y. Nikolsky, S. Ekins, T. Nikolskaya, and A. Bugrim A novel method for generation of signature networks as biomarkers from complex high throughput data Toxicology Letters 158 2005 20 29
133. Y. Nikolsky, T. Nikolskaya, and A. Bugrim Biological networks and analysis of experimental data in drug discovery Drug Discovery Today 10 2005 653 662
134. Y. Nishizato, I. Ieiri, H. Suzuki, M. Kimura, K. Kawabata, and T. Hirota Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics Clinical Pharmacology and Therapeutics 73 2003 554 565
135. T. Nozawa, M. Nakajima, I. Tamai, K. Noda, J. Nezu, and Y. Sai Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele frequencies in the Japanese population and functional analysis Journal of Pharmacology and Experimental Therapeutics 302 2002 804 813
136. T. Nozawa, S. Sugiura, M. Nakajima, A. Goto, T. Yokoi, and J. Nezu Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: Implications for understanding troglitazone hepatotoxicity Drug Metabolism and Disposition 32 2004 291 294
137. D.E. Oliver, D.L. Rubin, J.M. Stuart, M. Hewett, T.E. Klein, and R.B. Altman Ontology development for a pharmacogenetics knowledge base Package Symposion 2002 88 99
138. J.F. Oram, and R.M. Lawn ABCA1. The gatekeeper for eliminating excess tissue cholesterol Journal of Lipid Research 42 2001 1173 1179
139. M. Oswald, G.A. Kullak-Ublick, G. Paumgartner, and U. Beuers Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis Liver 21 2001 247 253
140. A.B. Parsons, R.I. Brost, H. Ding, Z. Li, C. Zhang, and B. Sheikh Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways Nature Biotechnology 22 2004 62 69
141. K.C. Patki, L.L. von Moltke, J.S. Harmatz, L.M. Hesse, M.H. Court, and D.J. Greenblatt Effect of age on in vitro triazolam biotransformation in male human liver microsomes Journal of Pharmacology and Experimental Therapeutics 308 2004 874 879
142. J.B. Pereira-Leal, A.J. Enright, and C.A. Ouzounis Detection of functional modules from protein interaction networks Proteins 54 2004 49 57
143. N. Plant Interaction networks: Coordinating responses to xenobiotic exposure Toxicology 202 2004 21 32
144. H.S. Raghavendra Prasad, Z. Qi, K.N. Srinivasan, and P. Gopalakrishnakone Potential effects of tetrodotoxin exposure to human glial cells postulated using microarray approach Toxicon 44 2004 597 608
145. T.P. Reilly, M. Bourdi, J.N. Brady, C.A. Pise-Masison, M.F. Radonovich, and J.W. George Expression profiling of acetaminophen liver toxicity in mice using microarray technology Biochemical and Biophysical Research Communications 282 2001 321 328
146. A.W. Rives, and T. Galitski Modular organization of cellular networks Proceedings of the National Academy of Sciences of the United States of America 100 2003 1128 1133
147. P.D. Rogers, M.M. Pearson, J.D. Cleary, D.C. Sullivan, and S.W. Chapman Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis Journal of Antimicrobial Chemotherapy 50 2002 811 817
148. M.B. Rosen, V.S. Wilson, J.E. Schmid, and L.E. Gray Gene expression analysis in the ventral prostate of rats exposed to vinclozolin or procymidone Reproductive Toxicology 19 2005 367 379
149. D. Rost, T. Herrmann, P. Sauer, H.L. Schmidts, B. Stieger, and P.J. Meier Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: Effect of ursodeoxycholate Hepatology 38 2003 187 195
150. R.B. Rothman, M.A. Ayestas, C.M. Dersch, and M.H. Baumann Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension Circulation 100 1999 869 875
151. S.U. Ruepp, R.P. Tonge, J. Shaw, N. Wallis, and F. Pognan Genomics and proteomics analysis of acetaminophen toxicity in mouse liver Toxicology Sciences 65 2002 135 150
152. T. Sakaeda, T. Nakamura, and K. Okumura MDR1 genotype-related pharmacokinetics and pharmacodynamics Biological & Pharmaceutical Bulletin 25 2002 1391 1400
153. T. Sakata, N. Anzai, H.J. Shin, R. Noshiro, T. Hirata, and H. Yokoyama Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions Biochemical and Biophysical Research Communications 313 2004 789 793
154. L.M. Satlin, V. Amin, and A.W. Wolkoff Organic anion transporting polypeptide mediates organic anion/HCO3-exchange Journal of Biological Chemistry 272 1997 26340 26345
155. Y. Satomi, W. Tsuchiya, K. Mihara, M. Ota, Y. Kasahara, and F. Akahori Gene expression analysis of the lung following paraquat administration in rats using DNA microarray Journal of Toxicological Sciences 29 2004 91 100
156. D. Schrenk, P.R. Baus, N. Ermel, C. Klein, B. Vorderstemann, and H.M. Kauffmann Up-regulation of transporters of the MRP family by drugs and toxins Toxicology Letters 120 2001 51 57
157. E. Segal, M. Shapira, A. Regev, D. Pe'er, D. Botstein, and D. Koller Module networks: Identifying regulatory modules and their condition-specific regulators from gene expression data Nature Genetics 34 2003 166 176
158. E. Segal, H. Wang, and D. Koller Discovering molecular pathways from protein interaction and gene expression Bioinformatics 19 2003 i264 i272
159. S.D. Seidel, H.L. Kan, W.T. Stott, M.R. Schisler, and B.B. Gollapudi Identification of transcriptome profiles for the DNA-damaging agents bleomycin and hydrogen peroxide in L5178Y mouse lymphoma cells Environmental and Molecular Mutagenesis 42 2003 19 25
160. L. Shan, Y. Yu, H.A.J. Schut, and E.G. Snyderwine Susceptibility of rats to mammary gland carcinogenesis by the food-derived carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) varies with age and is associated with the induction of differential gene expression American Journal of Pathology 165 2004 191 202
161. J.R. Sharom, D.S. Bellows, and M. Tyers From large networks to small molecules Current Opinion in Chemical Biology 8 2004 81 90
162. Y. Shitara, M. Hirano, H. Sato, and Y. Sugiyama Gemfibrozil and its glucuronide inhibit the OATP2(OATP1B1: SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin-Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil Journal of Pharmacology and Experimental Therapeutics 2004
163. Y. Shitara, T. Itoh, H. Sato, A.P. Li, and Y. Sugiyama Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A Journal of Pharmacology and Experimental Therapeutics 304 2003 610 616
164. R. Somogyi, S. Fuhrman, and X. Wen Genetic network inference in computational models and applications to large-scale gene expression data J.M. Bower H. Bolouri Computational modeling of genetic and biochemical networks 2001 The MIT Press Cambridge, MA 119 157
165. V. Spirin, and L.A. Mirny Protein complexes and functional modules in molecular networks Proceedings of the National Academy of Sciences of the United States of America 100 2003 12123 12128
166. J. Staudinger, Y. Liu, A. Madan, S. Habeebu, and C.D. Klaassen Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor Drug Metabolism and Disposition 29 2001 1467 1472
167. L.Z. Sun, Z.L. Ji, X. Chen, J.F. Wang, and Y.Z. Chen ADME-AP: A database of ADME associated proteins Bioinformatics 18 2002 1699 1700
168. L. Suter, L.E. Babiss, and E.B. Wheeldon Toxicogenomics in predictive toxicology in drug development Chemistry and Biology 11 2004 161 171
169. T.W. Synold, I. Dussault, and B.M. Forman The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux Nature Medicine 7 2001 584 590
170. Y. Tabuchi, and T. Kondo cDNA microarray analysis reveals chop-10 plays a key role in Sertoli cell injury induced by bisphenol A Biochemical and Biophysical Research Communications 305 2003 54 61
171. I. Tamai, J. Nezu, H. Uchino, Y. Sai, A. Oku, and M. Shimane Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family Biochemical and Biophysical Research Communications 273 2000 251 260
172. S.W. Taylor, E. Fahy, B. Zhang, G.M. Glenn, D.E. Warnock, and S. Wiley Characterization of the human heart mitochondrial proteome Nature Biotechnology 21 2003 281 286
173. S. Terasaka, Y. Aita, A. Inoue, S. Hayashi, M. Nishigaki, and K. Aoyagi Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals Environmental Health Perspectives 112 2004 773 781
174. D.M. Thomas, D.M. Francescutti-Verbeem, X. Liu, and D.M. Kuhn Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment-an oligonucleotide microarray approach Journal of Neurochemistry 88 2004 380 393
175. R.S. Thomas, D.R. Rank, S.G. Penn, G.M. Zastrow, K.R. Hayes, and K. Pande Identification of toxicologically predictive gene sets using cDNA microarrays Molecular Pharmacology 60 2001 1189 1194
176. K.L. Thompson, C.A. Afshari, R.P. Amin, T.A. Bertram, B. Car, and M. Cunningham Identification of platform-independent gene expression markers of cisplatin nephrotoxicity Environmental Health Perspectives 112 2004 488 494
177. R.G. Tirona, B.F. Leake, G. Merino, and R.B. Kim Polymorphisms in OATP-C: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans Journal of Biological Chemistry 276 2001 35669 35675
178. R.G. Tirona, B.F. Leake, A.W. Wolkoff, and R.B. Kim Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of the rifampin-mediated pregnane X receptor activation Journal of Pharmacology and Experimental Therapeutics 304 2003 223 228
179. W. Tong, X. Cao, S. Harris, H. Sun, H. Fang, and J. Fuscoe ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research Environmental Health Perspectives 111 2003 1819 1826
180. S. Tornow, and H.W. Mewes Functional modules by relating protein interaction networks and gene expression Nucleic Acids Research 31 2003 6283 6289
181. C. Trocho, J.C. Escola-Gil, V. Ribas, S. Benitez, J.M. Martin-Campos, and N. Rotllan Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration Atherosclerosis 174 2004 275 285
182. A. Ueda, H.K. Hamadeh, H.K. Webb, Y. Yamamoto, T. Sueyoshi, and C.A. Afshari Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital Molecular Pharmacology 61 2002 1 6
183. R.G. Ulrich The toxicogenomics of nuclear receptor agonists Current Opinion in Chemical Biology 7 2003 505 510
184. R.G. Ulrich, J.C. Rockett, G.G. Gibson, and S.D. Pettit Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression Environmental Health Perspectives 112 2004 423 427
185. A. Unami, Y. Shinohara, T. Ichikawa, and Y. Baba Biochemical and microarray analyses of bupivacaine-induced apoptosis Journal of Toxicological Sciences 28 2003 77 94
186. A. Vasquez, A. Flammini, A. Maritan, and A. Vespignani Global protein function prediction from protein-protein interaction networks Nature Biotechnology 21 2003 697 700
187. C.M. Vezina, N.J. Walker, and J.R. Olson Subchronic Exposure to TCDD, PeCDF, PCB126, and PCB153: Effect on hepatic gene expression Environmental Health Perspectives 112 2004 1636 1644
188. T.D. Vo, H.J. Greenberg, and B.O. Palsson Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data Journal of Biological Chemistry 279 2004 39532 39540
189. H. Wang, and E.L. LeCluyse Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes Clinical Pharmacokinetics 42 2003 1331 1357
190. N. Wang, D.L. Silver, C. Thiele, and A.R. Tall ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein Journal of Biological Chemistry 276 2001 23742 23747
191. J.F. Waring, G. Cavet, R.A. Jolly, J. McDowell, H. Dai, and R. Ciurlionis Development of a DNA Microarray for toxicology based on hepatoxin-regulated sequences Environmental Health Perspectives 111 2003 863 870
192. J.F. Waring, R. Gum, D. Morfitt, R.A. Jolly, R. Ciurlionis, and M. Heindel Identifying toxic mechanisms using DNA microarrays: Evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor Toxicology 181-182 2002 537 550
193. J.F. Waring, R.A. Jolly, R. Ciurlionis, P.Y. Lum, J.T. Praestgaard, and D.C. Morfitt Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles Toxicology and Applied Pharmacology 175 2001 28 42
194. M. Waters, G. Boorman, P. Bushel, M. Cunningham, R. Irwin, and A. Merrick Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base EHP Toxicogenomics 111 2003 15 28
195. M. Wei, L. Arnold, M. Cano, and S.M. Cohen Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium Toxicology Sciences 83 2005 237 245
196. R. Weinshilboum Inheritance and drug response New England Journal of Medicine 348 2003 529 537
197. R. Weinshilboum, and L. Wang Pharmacogenetics: Inherited variation in amino acid sequence and altered protein quantity Clinical Pharmacology and Therapeutics 75 2004 253 258
198. E. Werner In silico multicellular systems biology and minimal genomes Drug Discovery Today 8 2003 1121 1127
199. J.S. Wong, and S.S. Gill Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate Toxicology and Applied Pharmacology 185 2002 180 196
200. T. Xie, L. Tong, U.D. McCann, J. Yuan, K.G. Becker, and A.O. Mechan Identification and characterization of metallothionein-1 and -2 gene expression in the context of ()3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons Journal of Neuroscience 24 2004 7043 7050
201. F. Yadetie, A. Laegreid, I. Bakke, W. Kusnierczyk, J. Komorowski, and H.L. Waldum Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate Physiological Genomics 15 2003 9 19
202. S. Yamashita, T. Nomoto, M. Abe, M. Tatematsu, T. Sugimura, and T. Ushijima Persistence of gene expression changes in stomach mucosae induced by short-term N-methyl-N′-nitro-N-nitrosoguanidine treatment and their presence in stomach cancers Mutation Research 549 2004 185 193
203. Q. Yan, and W. Sadee Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics AAPS Pharmsci 2 2000 E20
204. E. Yeger-Lotem, and H. Margalit Detection of regulatory circuits by integrating the cellular networks of protein-protein interactions and transcription regulation Nucleic Acids Research 31 2003 6053 6061
205. B.I. Yoon, G.-X. Li, K. Kitada, Y. Kawasaki, K. Igarashi, and Y. Kodama Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue Environmental Health Perspectives 111 2003 1411 1420
206. M.B. Young, M.R. DiSilvestro, T.J. Sendera, J. Freund, A. Kriete, and S.R. Magnuson Analysis of gene expression in carbon tetrachloride-treated rat livers using a novel bioarray technology Pharmacogenomics Journal 3 2003 41 52
207. H. Yu, X. Zhu, D. Greenbaum, J. Karro, and M. Gerstein TopNet: A tool for comparing biological sub-networks, correlating protein properties with topological statistics Nucleic Acids Research 32 2004 328 337
208. E.Y. Zhang, D.J. Fu, Y.A. Pak, T. Stewart, N. Mukhopadhyay, and S.A. Wrighton Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: Implications for the functional role of Pro586 Journal of Pharmacology and Experimental Therapeutics 310 2004 437 445
209. E.Y. Zhang, G.T. Knipp, S. Ekins, and P.W. Swaan Structural biology and function of solute transporters: Implications for identifying and designing substrates Drug Metabolism Reviews 34 2002 709 750
210. E.Y. Zhang, M.A. Phelps, C. Cheng, S. Ekins, and P.W. Swaan Modeling of active transport systems Advanced Drug Delivery Reviews 54 2002 329 354